Skip to main content

Local anesthetic toxicity and lipid rescue...



"A Mixed (long- and Medium-chain) Triglyceride Lipid Emulsion Extracts Local Anesthetic from Human Serum In Vitro More Effectively than a Long-chain Emulsion"

Anesthesiology, February 2012




Researchers in the U.K. analyzed the difference between mixed (medium- and long-chain) and long-chain lipid emulsions, for their ability to extract local anesthetic from serum. They concluded that the type of emulsion may make the reversal more effective.


The authors used human drug-free serum and added bupivacaine, ropivacaine, or mepivacaine each at a concentration of 10 µg/ml, or bupivacaine 100 µg/ml at pH 7.4, and, in another experiment, bupivacaine 10 µg at pH 6.9. 20% Intralipid®, which has long-chain triglycerides, or 20% Lipofundin®, which contains a 50-50% mixture of medium- and long-chain triglycerides, was then added at 1, 2, or 4% of total volume. The mean decrease in serum drug concentration was then calculated.

The authors’ in vitro model showed overall that Lipofundin® was significantly better than Intralipid® in extracting the drugs from serum. The relative degree of extraction was bupivacaine > ropivacaine > mepivacaine. This order is consistent with the relative partition constant of each drug. As higher concentrations of either Intralipid® or Lipofundin® were used, the percent decrease of bupivacaine increased and a greater effect was seen with Lipofundin® at each % of lipid. A larger percent decrease in serum bupivacaine was observed after 100 µg/ml bupivacaine compared to 10 µg/ml for both Intralipid® and Lipofundin®, and Lipofundi®n extracted more bupivacaine than Intralipid® at each concentration of either lipid. The effect of pH on sequestering bupivacaine was not significant.

These findings call into question the current advanced cardiac life support guidelines specifying use of a long-chain triglyceride emulsion for lipid rescue, although further in vivo studies that confirm a significant improvement in resuscitation from local anesthetic toxicity with lipofundin are obviously required before drawing any confident conclusions. Also, Lipofundin® is currently commercially unavailable in the United States. Indeed, though the study was performed in the United States, the Lipofundin emulsion that was used was a gift from the manufacturer B. Braun Melsungen AG (Melsungen, Germany)

Labels:

Comments

Post a Comment

Popular posts from this blog

Falling from Height...The Prognostic factors

Falls from Height is Knwon to cause major morbidities and mortalities.  There are several prognostic factors for survival that have been identified: Height Age Type of surface Body part that touches the ground first Two other factors are important, but do not have a significant effect on mortality: Circumstances of the fall (suicide, accident, escape) Initial impact with an object before impacting the ground Height . Overall, about half of victims die at the scene, and a total of 70% die before they reach the hospital . The median height leading to death is about 49 feet, or about 4 to 5 storeys. 100% of victims die after falling 85 feet, or about 8 storeys. Age . Mortality increases with age due to pre-existing medical conditions and decreased physiologic reserve. Type of surface . The type of surface struck (i.e. grass, water, construction debris) can also have an effect on secondary injuries and survival. Mortality after striking a hard surface is nearly doubl...
Post a Comment
Read more

power injectable peripherally inserted central catheters

Clinical experience with power injectable peripherally inserted central catheters in intensive care patients     Introduction In intensive care units (ICU), peripherally inserted central catheters (PICC) may be an alternative option to standard central venous catheters, particularly in patients with coagulation disorders or at high risk for infection. Some limits of PICCs (such as low flow rates) may be overcome by the use of power-injectable catheters . Method We have retrospectively reviewed all the power injectable PICCs inserted in adult and pediatric patients in the ICU during a 12-month period, focusing on the rate of complications at insertion and during maintenance. Results We have collected 89 power injectable PICCs (in adults and in children), both multiple and single lumen. All insertions were successful. There were no major complications at insertion and no episodes of catheter-related blood stream infection. Non-infective complications ...
1 comment
Read more

The 12 decision making steps for post dural puncture headache treatment

Treatment decision-making algorithm for postdural puncture headache. 1. When diagnosis is made, all patients should receive supportive measures (reassurance, bed rest, analgesics, hydration, quiet environment). 2. Severity of symptoms should be classified using VAS scale (mild 1–3, moderate 4–6, severe 7–10). 3. Virtually all patients will improve in time even without additional therapy. (dashed lines) 4. Symptoms worsen or fail to resolve within 5 days. 5. Patient preference dictates the choice between pharmacologic (less effective) and epidural blood patch (EBP). 6. In patients with severe symptoms, EBP is strongly suggested. 7. The most common pharmacologic measure is  caffeine  prescription. 8. The failure, worsening, or recurrence of symptoms after pharmacologic measures favors the use of EBP. 9. In addition to EBP, other epidural treatment options can be considered in select patients (eg,  dextran , saline). 10. A period of 24 h should lapse before repeating EBP. 11...
1 comment
Read more